BIA reacts to £400m investment in the UK by Fujifilm Diosynth Biotechnologies

Reacting to news that Fujifilm Diosynth Biotechnologies will be investing £400m into their UK manufacturing operation, Steve Bates OBE, Chief Executive of the Bioindustry Association said: “This is one of the largest investments in bio manufacturing we have seen in recent decades, creating state of the art manufacturing capability in RNA and cell and gene therapies. For a global player such as Fujifilm Diosynth Biotechnologies to make an investment of this size shows the vibrancy of the UK life sciences ecosystem and this investment will be pivotal in establishing the Northeast of England as one of the key clusters in the UK life sciences sector going forward.”